The same phenomenon is also observed in CLL patients, where PIM2 expression has been reported to be significantly higher in their leukemic cells compared to its expression in peripheral blood lymphocytes of controls. The gene discussed is PIM2; the disease is B-cell chronic lymphocytic leukemia.